| Tag | Content |
|---|
EnhancerAtlas ID | HS091-17283 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr16:50360480-50362570 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| POU2F2 | MA0507.1 | chr16:50361947-50361960 | CACATTTGCATAT | + | 6.64 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_11181 | chr16:50360121-50365058 | CD20 | | SE_12248 | chr16:50360420-50362067 | CD3 | | SE_20409 | chr16:50359834-50364592 | CD56 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I050326 | chr16 | 50360043 | 50362601 |
|
Enhancer Sequence | AGCCAGGACC AAAACTCAGA CCTGTTCATT ACACTCTCCT GCTTCCTGGA ATTCTTTATA 60
ATCATGTACA CTTCACTTAA AAAATTAATT TTTATTAAAA ACAAAAGCCA CAAAAACTTT 120
TAAAAGCTGG GACTTTTAAT GTTAAGATGA AAGTTAACCA GTACAAAGGT TAGTAAAAGA 180
CTGAGGGAAA ACACCTGCAT TAAAGACAAA AGGGCTACTA ACACATGAAG GATAAATGAG 240
TATCTATGAA AGGCATACTT TTAGTGCAAC GAGAACAGGC ATTAGCCAGG AATGAATCCC 300
TGTGATGAAG CTGGGAATAC GTGACATAGA GAAATGTCAC GTATGGGCAC CTGAGGGGAC 360
TGCAAAAGAT GCTGGCAGGA GAAGATGTGG TCTCCCACAG TATCTAACAG AGGGACATCT 420
GCTCTCCTGA AGAAGAGTCT GAGTTTGTGT CACATGATCA GCCTTCAACG GAGGCTACTG 480
CCATCAGTGA CCAGTGTGGT GAAGGCACTG TTAAGCAACT GAACATCTAA ATCAGATCTT 540
CTCTCCTCAG CCAACAGTCT GGAATTTGGT TTCCTAATAG GTACGGGTAC CAGACAATGA 600
AGCTGAGAAG ATGAACAGGG GTGTCTTCTA CCTTAAACCA TGAAAGTGGC CTACAGAGGG 660
AGCTGTGCAC ACGGGGAGCC AAGTCAGCTT TGGCCACATT TGATTAGGTC TCAGAAACTG 720
GAAACCCAGG AAACCAGAGC AAGGACAGAG ACCACACTCG GCTTCACAGA AAGCAGCAGA 780
TCTTAAGGTG TCACCTACAT CAGTTAGCTG CATCTCCTAA CACCAAATGT TCACCACAGC 840
TATAGTAGAA AGAGCAATGT TCTCAATCCT GTGGCATTCT TTGACCTATG ATCATATAAA 900
ATTCTACTTG TCTGCATCAA AGTAGAAACT GAGTTTTGTT TTGAAAACAG CACTAGCTCC 960
TTTTCTTCTA TTACTGTTCT CCTCCTTTAG AGAACATTCA TAGTCCCCTT CTTTCCATCT 1020
TCAAATGCTC TTCCCTGCTT CAAGGTTTTC ACAACTGCTG TTCTCTCATC CCTTACTCAA 1080
CCTAAACATC ATCTCCTTAA GGATGCCTTC CCTGACCCCC AAACACTAGG TTGGTATCTT 1140
CTATTATGAT CATAGCTGTT CTTTTCCTTT GTAGTATTTA TTCATTATAG ACACACACCT 1200
GCATAGTACT GATTAAGGAC AGACTTCTCT TTATGTGAGT CCTCTTCCCC CGACTCCATA 1260
GAACAAGGAA AAGGGACTCC TCTCTCTCTG TTTTGTTCTC TACTACACAG CTAGCTCCTA 1320
AGACAGCACC CTGCTCACAG CAAACAATAA ACATCAGAGA CTGTTTCCTT AAGGGTAAAA 1380
ATTCTGTCAT TATTCATTTT CGTATTTCCA ATTACTTCTT TCATTATGAC AGTATGAAAA 1440
TAAATTTGTT GAATAAATTA ACATTCTCAC ATTTGCATAT CTCAATACAT GATTCTCTCC 1500
TCAGACCAGT GACAAAAAGT TCTAATTGTG ACATCGAATT TCAAAATATA ACCTATATGA 1560
TTTCCATTAA AACATCATTT GAGAAAACAA AAATATGACT GAGGTTCTAA AGATTCCCAA 1620
TCTTTACAAA CTTTCTACTG ACTATAGTGA AAGATACGAT GTCACTAAGC ATACACCTTC 1680
CATTATTATT AAGGCACTAT GTGGCATATA CATTCATTTT ATTCCCTGAA ATAAACAGTT 1740
AAATTTATAA TATCATATTC TGTGTGTATG AGATACCTCT AAACTGAGTG TCTATACTAA 1800
AGTCTCTTAA AACCAGGGCT AGGAATTACT ATCTAAAAGT TATGGCTTTG TTAATGGCGG 1860
GTTTAAAATA TTTCAGGGAC TTTGAATTTT AAGGAAAACT TGATATACTG TACCTATTTC 1920
AAGATGAAGT GAAAGTTAGG CTAGCTGTTA CCATGAAATA CATGATGTCT AGCTAGATCC 1980
TTTGTGCATA ATGACACAGA CTGATCAATA TTCAAGCTTG TTGCTTTAAA ATGTTAACCC 2040
AGGTTACTGT TCTCTGCCAA ATAGCATCAA GTTCATGCAC AGTTTTACTC 2090
|
